CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
49,738,980
Share change
-11,320,481
Total reported value
$96,996,762
Put/Call ratio
32%
Price per share
$1.95
Number of holders
89
Value change
-$20,957,355
Number of buys
50
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q2 2015

As of 30 Jun 2015, CTI BIOPHARMA CORP - COM (CTIC) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,738,980 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, Lombard Odier Asset Management (USA) Corp, STATE STREET CORP, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, Candriam Luxembourg S.C.A., and OXFORD ASSET MANAGEMENT. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.